260 related articles for article (PubMed ID: 33971964)
1. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia.
Thej C; Balasubramanian S; Rengasamy M; Walvekar A; Swamynathan P; Raj SS; Shahani P; Siddikuzzaman ; Kolkundkar U; Seetharam RN; Gupta PK; Majumdar AS
Stem Cell Res Ther; 2021 May; 12(1):279. PubMed ID: 33971964
[TBL] [Abstract][Full Text] [Related]
2. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
[TBL] [Abstract][Full Text] [Related]
3. Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product.
Thej C; Ramadasse B; Walvekar A; Majumdar AS; Balasubramanian S
Stem Cell Res Ther; 2017 Feb; 8(1):47. PubMed ID: 28245882
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint.
Gupta PK; Chullikana A; Rengasamy M; Shetty N; Pandey V; Agarwal V; Wagh SY; Vellotare PK; Damodaran D; Viswanathan P; Thej C; Balasubramanian S; Majumdar AS
Arthritis Res Ther; 2016 Dec; 18(1):301. PubMed ID: 27993154
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Biological Properties of Human Adult Mesenchymal Stem Cells and Their Effect on Mouse Hind Limb Ischemia.
García-Vázquez MD; Herrero de la Parte B; García-Alonso I; Morales MC
J Vasc Res; 2019; 56(2):77-91. PubMed ID: 31079101
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
9. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
10. Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in Mice.
Wang Z; Zheng L; Lian C; Qi Y; Li W; Wang S
Stem Cells Dev; 2019 Oct; 28(20):1384-1397. PubMed ID: 31407635
[TBL] [Abstract][Full Text] [Related]
11. Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model.
van Rhijn-Brouwer FCC; Gremmels H; Den Ouden K; Teraa M; Fledderus JO; Verhaar MC
Stem Cells Dev; 2022 Apr; 31(7-8):176-180. PubMed ID: 35152731
[TBL] [Abstract][Full Text] [Related]
12. An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model.
Whiteley J; Bielecki R; Li M; Chua S; Ward MR; Yamanaka N; Stewart DJ; Casper RF; Rogers IM
Stem Cell Rev Rep; 2014 Jun; 10(3):338-50. PubMed ID: 24443055
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
14. Xenotransplantation of neonatal porcine bone marrow-derived mesenchymal stem cells improves murine hind limb ischemia through lymphangiogenesis and angiogenesis.
Yamada H; Sakata N; Nishimura M; Tanaka T; Shimizu M; Yoshimatsu G; Kawakami R; Wada H; Sawamoto O; Matsumoto S; Kodama S
Xenotransplantation; 2021 Jul; 28(4):e12693. PubMed ID: 33960029
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.
Cunha FF; Martins L; Martin PK; Stilhano RS; Han SW
Stem Cell Res Ther; 2013 Jul; 4(4):86. PubMed ID: 23890057
[TBL] [Abstract][Full Text] [Related]
16. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.
Moon MH; Kim SY; Kim YJ; Kim SJ; Lee JB; Bae YC; Sung SM; Jung JS
Cell Physiol Biochem; 2006; 17(5-6):279-90. PubMed ID: 16791003
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia.
Francki A; Labazzo K; He S; Baum EZ; Abbot SE; Herzberg U; Hofgartner W; Hariri R;
J Vasc Surg; 2016 Sep; 64(3):746-756.e1. PubMed ID: 26054585
[TBL] [Abstract][Full Text] [Related]
18. A 3-month Safety Assessment of Human Bone Marrow Derived Mesenchymal Stromal Cells Administered Once by the Intramuscular Route to Immunodeficient Mice.
Creane M; McElroy M; Duffy A; Dawood CS; O'Brien T
Toxicol Pathol; 2018 Apr; 46(3):290-301. PubMed ID: 29504494
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.
Koch JM; D'Souza SS; Schwahn DJ; Dixon I; Hacker TA
Cytotherapy; 2016 Feb; 18(2):219-28. PubMed ID: 26740280
[TBL] [Abstract][Full Text] [Related]
20. Alginate-Encapsulated Mesenchymal Stromal Cells Improve Hind Limb Ischemia in a Translational Swine Model.
Deppen JN; Ginn SC; Tang EO; Wang L; Brockman ML; Levit RD
J Am Heart Assoc; 2024 May; 13(9):e029880. PubMed ID: 38639336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
